Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 3.96%1.5B | 7.82%331M | 11.15%349M | -11.52%453M | 18.51%365M | 1.77%1.44B | -14.72%307M | -9.77%314M | 14.54%512M | 18.01%308M |
Net income from continuing operations | -5.98%707M | -18.66%109M | -25.66%84M | 13.08%242M | -6.53%272M | 16.95%752M | -10.07%134M | -2.59%113M | -17.69%214M | 146.61%291M |
Operating gains losses | -250.00%-7M | 400.00%5M | -150.00%-2M | 50.00%-2M | -166.67%-8M | 33.33%-2M | --1M | 300.00%4M | -100.00%-4M | -50.00%-3M |
Depreciation and amortization | 9.33%762M | 5.91%197M | 13.22%197M | 11.90%188M | 6.51%180M | 4.97%697M | 12.05%186M | 6.10%174M | 3.70%168M | -1.74%169M |
Deferred tax | -69.23%8M | ---- | ---- | ---- | ---- | 30.00%26M | ---- | ---- | ---- | ---- |
Other non cash items | -671.43%-120M | -5.88%-18M | -315.79%-41M | -165.45%-36M | 30.56%-25M | 261.54%21M | -525.00%-17M | 1,050.00%19M | 1,200.00%55M | -260.00%-36M |
Change In working capital | 192.98%106M | 142.22%19M | 2,625.00%101M | -20.97%49M | 50.39%-63M | -332.65%-114M | -742.86%-45M | -107.02%-4M | 588.89%62M | -429.17%-127M |
-Change in receivables | ---- | ---- | 600.00%91M | ---- | ---- | ---- | ---- | --13M | ---- | ---- |
-Change in other current assets | -200.00%-9M | -50.00%5M | -79.31%-52M | 130.77%30M | 166.67%8M | -115.00%-3M | -23.08%10M | 19.44%-29M | -72.92%13M | 160.00%3M |
-Change in other current liabilities | 164.79%46M | -500.00%-4M | 416.67%62M | 102.38%1M | 69.05%-13M | -607.14%-71M | -90.91%1M | 50.00%12M | -566.67%-42M | -200.00%-42M |
-Change in other working capital | 272.50%69M | ---- | ---- | ---- | 34.09%-58M | -366.67%-40M | ---- | ---- | ---- | -1,660.00%-88M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 3.96%1.5B | 7.82%331M | 11.15%349M | -11.52%453M | 18.51%365M | 1.77%1.44B | -14.72%307M | -9.77%314M | 14.54%512M | 18.01%308M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,014.75%-2.04B | -336.25%-189M | -9,066.67%-1.08B | -297.06%-675M | 4.76%-100M | 70.39%-183M | 117.94%80M | 110.71%12M | -631.25%-170M | -14.13%-105M |
Capital expenditure reported | 15.17%-548M | 0.57%-173M | -1.34%-151M | 31.64%-121M | 29.45%-103M | -28.17%-646M | -18.37%-174M | -27.35%-149M | -50.00%-177M | -19.67%-146M |
Net business purchase and sale | -30,160.00%-1.5B | -120.00%-1M | ---936M | ---- | ---- | 101.66%5M | --5M | --0 | ---- | ---- |
Net other investing changes | -97.60%11M | -106.02%-15M | -93.17%11M | 71.43%12M | -92.68%3M | 144.92%458M | 12,350.00%249M | 3,120.00%161M | -95.33%7M | 36.67%41M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,014.75%-2.04B | -336.25%-189M | -9,066.67%-1.08B | -297.06%-675M | 4.76%-100M | 70.39%-183M | 117.94%80M | 110.71%12M | -631.25%-170M | -14.13%-105M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 98.31%-13M | 13.94%-142M | 329.52%482M | -251.14%-309M | 85.71%-44M | 11.78%-771M | -43.48%-165M | -377.27%-210M | -300.00%-88M | 55.56%-308M |
Net issuance payments of debt | 12,628.57%877M | --0 | 68,900.00%688M | -11,000.00%-111M | --300M | 98.98%-7M | -400.00%-5M | ---1M | 0.00%-1M | --0 |
Net common stock issuance | 41.21%-107M | --0 | 43.00%-57M | ---50M | --0 | -574.07%-182M | -14.29%-32M | -10,100.00%-100M | --0 | ---50M |
Cash dividends paid | -34.73%-737M | -9.45%-139M | -31.78%-141M | -65.88%-141M | -38.60%-316M | -264.67%-547M | -49.41%-127M | -143.18%-107M | -304.76%-85M | ---228M |
Net other financing activities | -31.43%-46M | -200.00%-3M | -300.00%-8M | -250.00%-7M | 6.67%-28M | -191.67%-35M | 0.00%-1M | -100.00%-2M | ---2M | -200.00%-30M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 98.31%-13M | 13.94%-142M | 329.52%482M | -251.14%-309M | 85.71%-44M | 11.78%-771M | -43.48%-165M | -377.27%-210M | -300.00%-88M | 55.56%-308M |
Net cash flow | ||||||||||
Beginning cash position | 55.95%1.36B | -29.24%806M | 2.34%1.05B | 105.45%1.58B | 55.95%1.36B | -8.29%874M | 6.05%1.14B | 15.82%1.03B | 79.07%770M | -8.29%874M |
Current changes in cash | -213.96%-555M | --0 | -311.21%-245M | -309.06%-531M | 310.48%221M | 740.79%487M | 210.45%222M | -39.58%116M | -44.42%254M | 79.96%-105M |
Effect of exchange rate changes | -600.00%-10M | -500.00%-8M | 200.00%2M | -300.00%-2M | -300.00%-2M | 166.67%2M | 100.00%2M | 33.33%-2M | 150.00%1M | 0.00%1M |
End cash Position | -41.45%798M | -41.45%798M | -29.24%806M | 2.34%1.05B | 105.45%1.58B | 55.95%1.36B | 55.95%1.36B | 6.05%1.14B | 15.82%1.03B | 79.07%770M |
Free cash flow | 19.50%950M | 18.80%158M | 20.00%198M | -0.90%332M | 61.73%262M | -12.83%795M | -37.56%133M | -28.57%165M | 1.82%335M | 16.55%162M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |